Remarkably, loss of Tie2-expressing MDMs completely abrogated neovascularization in human glioblastoma-derived tumor-bearing mice, suggesting that selectively targeting Tie2-expressing MDMs may be another potential therapeutic avenue (87). This evidence concerns the gene TEK and neoplasm.